New hope for tough pancreatic cancer? early trial combines two drugs
Disease control
Not yet recruiting
This early-phase trial tests two drugs (cosibelimab and balixafortide) together in people with advanced pancreatic cancer that has stopped responding to standard chemotherapy. The main goal is to find the safest dose and check for side effects. About 24 adults will take part in t…
Phase: PHASE1 • Sponsor: Arsen Osipov • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC